Skip to main navigation
Skip to search
Skip to main content
Sort by:
Keyphrases
Sclerostin
76%
Proteolysis Targeting chimera (PROTAC)
57%
Aptamer
50%
Liver
34%
Small Molecules
31%
Bone Anabolic Effects
30%
MiRNA-mRNA Interaction
28%
Deep Learning Methods
28%
Binding Affinity
28%
Target miRNA
28%
Quinoline
28%
Modified Aptamers
28%
Web Services
28%
Target mRNA
28%
Tumor-targeted Therapy
28%
Paclitaxel
28%
Peptide Aptamer
28%
Design Strategy
28%
Cancer Therapy
28%
Cardiovascular System
28%
Tumor Therapy
28%
Triple-negative Breast Cancer
28%
Hypoxia-activated Prodrug
28%
Hypoxia Inhibitors
28%
Hypoxia
28%
Protein Degradation
28%
Specificity Protein 1
28%
GalNAc
28%
Dual Action
28%
Liver-specific
28%
Bone Disorders
28%
Duchenne muscular Dystrophy
28%
Osteoarthritis
28%
Bile Acids
28%
CCL20
28%
Immunotherapeutic Strategy
28%
Glycogen Synthase kinase-3β (GSK-3β)
28%
B-cell Maturation Antigen
28%
Nuclear factor-B
28%
Macrophages
28%
Macrophage Polarization
28%
Iron-sulfur
28%
CDGSH
28%
Xanthatin
28%
Nano-drug Delivery System
28%
Molecular Insight
28%
Bile Acid Homeostasis
28%
Chondrocytes
28%
Pharmacological Strategies
28%
Betulinic Acid
28%
Host Disease
28%
Dystrophin
22%
Mature microRNAs
19%
MicroRNA
19%
Hypoxia-inducible factor-1α (HIF-1α)
17%
Folic Acid
15%
Targeted Cancer Therapy
14%
Asialoglycoprotein Receptor (ASGPR)
14%
Selection Tool
14%
High-throughput SELEX
14%
Data Engine
14%
Dataset Modeling
14%
Closed Ecosystem
14%
Inverse Folding
14%
Data Interpretability
14%
Computational Discovery
14%
Artificial Intelligence Framework
14%
Discovery Method
14%
Clinical Translation
14%
Osteogenesis Imperfecta
12%
Linker
12%
Nanoparticle Gel
12%
Therapeutic Efficacy
11%
Protein of Interest
11%
Tumor
11%
Drug Resistance
11%
Breast Cancer Treatment
11%
Nanomedicine
11%
Prodrug Activation
11%
Therapeutic Strategies
11%
Two-line
11%
Bone Formation
10%
Computational Program
9%
Disease-related
9%
Translational Repression
9%
Unique Functions
9%
Target RNA
9%
Network Approach
9%
Gene Silencing
9%
Structural Motif
9%
Mature miRNA
9%
Neural Network
9%
In Silico
9%
Argonaute
9%
Secondary Structural Elements
9%
Therapeutic Target
9%
Pharmacological Screening
9%
Small-molecule Drug Discovery
9%
Candidate Small Molecules
9%
Convolutional Neural Network
9%
Drug Target Discovery
9%
Functional Loops
9%
Small Molecule Drugs
9%
Single Guide RNA (sgRNA)
9%
Systemic Clearance
9%
Hepatocytes
9%
Sclerostin Antibody
9%
Synovitis
9%
M1 Macrophages
9%
Aptamer Engineering
9%
Molecular Lock
9%
Paclitaxel Chemoresistance
9%
Structural Stabilizer
9%
Enhanced Cellular Internalization
9%
Molecular Mechanism
8%
High Affinity
8%
COL1A2
8%
Bone Turnover Markers
8%
Wnt Signaling
8%
Wnt Signaling Pathway
8%
Molecular Recognition
8%
Cardiovascular Risk
8%
Bifunctional Molecules
7%
Therapeutic Challenges
7%
Drug Loading Capacity
7%
Structural Features
7%
Effective Approach
7%
Patient Outcomes
7%
Clinical Application
7%
Specific Targeting
7%
Cancer Cells
7%
Low Immunogenicity
7%
Unique Properties
7%
Therapeutic Potential
7%
Adverse Effects
7%
Tissue Penetration
7%
Functional Peptides
7%
Antigen Escape
7%
Chimeric Antigen Receptor T-cell Therapy
7%
B Cell Maturation
7%
Cartilage Regeneration
6%
Homeostasis
6%
Physiological Function
6%
Bile Acid Pool
6%
Metabolic Disorders
6%
Inhibitory Effect
6%
Romosozumab
6%
Active Form
5%
Therapy Strategy
5%
Potential Therapeutics
5%
Targeted Therapy
5%
Tumor Inhibition
5%
Acidic Conditions
5%
Tumor Hypoxia
5%
MRNA Expression
5%
Targeted Tumor
5%
Chemotherapy
5%
Combretastatin A4 Phosphate (CA4P)
5%
Hypoxia-activated
5%
AQ4N
5%
Dual-responsive
5%
Smart Nanomedicine
5%
Breast Cancer Targeting
5%
Breast Cancer Subtypes
5%
Reductive Conditions
5%
Self-assembled Nanodrugs
5%
Chemosensitization
5%
Carrier-free
5%
Antisense Oligonucleotides
5%
Glucocorticoid Therapy
5%
Pathological Changes
5%
Symptom Relief
5%
Inflammatory Fibrosis
5%
Neuromuscular Disease
5%
Muscle Stem Cell (MuSC)
5%
Current Therapeutics
5%
Chronic Inflammation
5%
Muscle Function
5%
Gene Expression Profiling
5%
Cell-based
5%
Targeted Therapeutics
5%
Clinical Phases
5%
Muscle Quality
5%
Progressive Fibrosis
5%
Fiber Integrity
5%
Muscle Fiber
5%
Muscle Atrophy
5%
Myofiber
5%
Standard of Care
5%
Protein Replacement Therapy
5%
Meta-analysis
5%
X-linked
5%
Gene-based
5%
Pharmacology, Toxicology and Pharmaceutical Science
Aptamer
97%
Sclerostin
81%
Neoplasm
66%
Paclitaxel
57%
Malignant Neoplasm
50%
Messenger RNA
31%
Bone Disease
30%
microRNA
28%
Peptide Aptamer
28%
Hypoxia Inducible Factor
28%
Hypoxia
28%
Prodrug
28%
Ltvax
28%
Glycogen Synthase Kinase 3beta
28%
Osteoarthritis
28%
Alternative Complement Pathway C3 C5 Convertase
28%
Bile Acid
28%
Duchenne Muscular Dystrophy
28%
Betulinic Acid
28%
Nuclear Factor
28%
Telomerase
28%
Ovary Cancer
28%
Dystrophin
22%
Folic Acid
19%
Nanoparticle
19%
Drug Resistance
14%
Triple Negative Breast Cancer
12%
Clinical Study
12%
Fibrosis
11%
Osteogenesis Imperfecta
11%
Combination Therapy
11%
Nanomedicine
10%
Diseases
9%
Synovitis
9%
Inflammation
9%
Cancer Inhibition
9%
Ovary Carcinoma
9%
Nucleolin
9%
Guanine Quadruplex
9%
Chemotherapy Regimen
9%
Drug Discovery
8%
Cardiovascular Disease
7%
Cardiovascular Risk
7%
Immunogenicity
7%
Nucleic Acid
7%
Proteasome
7%
Ubiquitin
7%
Clinical Trial
7%
Preference
7%
Side Effect
7%
Romosozumab
5%
Glucocorticoid
5%
Chronic Inflammation
5%
Replacement Therapy
5%
Muscle Atrophy
5%
Neuromuscular Disease
5%
Receptor
5%
Biochemistry, Genetics and Molecular Biology
Aptamer
100%
Sclerostin
57%
Messenger RNA
42%
Small Molecule
31%
Artificial Intelligence
31%
Binding Affinity
28%
MicroRNA
28%
Proteolysis
28%
Drug Resistance
28%
Hypoxia-Inducible Factors
28%
Protein Catabolism
28%
Lysosome
28%
Bile Acid
28%
Homeostasis
28%
Dystrophin
28%
Oligonucleotide
21%
Ossification
15%
Sensitization
14%
In Vivo Study
14%
Antisense
14%
Tumor Hypoxia
14%
Targeted Therapy
14%
Combretastatin
14%
Tumor Progression
14%
Molecular Recognition
14%
Wnt Signaling Pathway
13%
RNA
12%
Bone Development
11%
Nucleic Acid
10%
Hepatocyte
9%
Drug Development
8%
Facilitated Diffusion
7%
Evolution
7%
De Novo Design
7%
Clinical Study
7%
Muscle Function
7%
Xanthium
7%
Stem Cell
7%
Glucocorticoid
7%
Anabolism
5%